お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
371116

フランスのコンシューマーヘルス市場

Consumer Health in France

出版日: | 発行: Euromonitor International | ページ情報: 英文 123 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.27円
フランスのコンシューマーヘルス市場
出版日: 2020年10月28日
発行: Euromonitor International
ページ情報: 英文 123 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、フランスのコンシューマーヘルス (OTC医薬品) 市場について包括的に調査分析し、最新の小売販売データ、主要企業プロファイル、主要ブランドについて検証するほか、市場に影響を与える戦略的分析、市場予測などについて、体系的な情報を提供しています。

フランスのコンシューマーヘルス市場:産業の概要

  • エグゼクティブサマリー
  • 主要動向と発展
  • 市場指標
  • 市場データ
  • 付録
    • OTC医薬品の登録と分類
    • ビタミン・栄養補助食品の規制と分類
    • 大衆薬/自己治療と予防薬
    • スイッチOTC
  • 定義
  • 情報源

フランスのコンシューマーヘルス市場:企業プロファイル

  • Johnson & Johnson Sante Beaute France SA
  • Laboratoires Arkopharma SA
  • Laboratoires Urgo Sas
  • Naturhouse Sas
  • Sanofi

※以下カテゴリーは、分冊での販売も承っております。価格や内容については、お問い合わせください。

フランスのコンシューマーヘルス市場:カテゴリー分析

  • 鎮痛剤
  • 睡眠薬
  • 咳・風邪・アレルギー (花粉症) 治療薬
  • 皮膚薬
  • 胃腸薬
  • アイケア
  • NRT (ニコチン置換療法) 禁煙補助薬
  • 創傷ケア
  • スポーツ栄養
  • ビタミン・サプリメント
  • 体重管理製品
  • ハーブ/伝統薬
目次
Product Code: CHFR

The outbreak of COVID-19 is expected to lead to an increase in growth and sales for consumer health products in 2020, with 4% value growth predicted, compared to 1% recorded in 2019. Much of this growth will be driven by panic buying, with some French consumers stockpiling goods during Q1 and Q2 of 2020 when the lockdown was in place, with consumers ensuring they had essential goods in the home. Many consumers were also concerned about contracting the virus, and therefore, they wanted to have me...

Euromonitor International's‘Consumer Health in France report’ offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market's major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

TABLE OF CONTENTS

List OF CONTENTS AND TABLES

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
  • Table 2 Life Expectancy at Birth 2015-2020

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2015-2020
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2015-2020
  • Table 5 NBO Company Shares of Consumer Health: % Value 2016-2020
  • Table 6 LBN Brand Shares of Consumer Health: % Value 2017-2020
  • Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2015-2020
  • Table 8 Distribution of Consumer Health by Format: % Value 2015-2020
  • Table 9 Distribution of Consumer Health by Format and Category: % Value 2020
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2020-2025
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

    • Summary 1 OTC: Switches 2019-2020

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

    • Summary 2 Research Sources

KEY DATA FINDINGS

2020 IMPACT

Acetaminophen benefits from the outbreak of COVID-19 as the Minster of Health recommends its use to fight off a fever

Nonsteroidal analgesics and anti-inflammatory medications move from over-the-counter, to behind-the-counter status

Sanofi benefits from the increasing interest in paracetamol as leading product Doliprane improves its share

RECOVERY AND OPPORTUNITIES

Better performance across the forecast period, as acetaminophen continues to improve its growth

Codeine restrictions put a damper on growth for the forecast period, with anti-inflammatories and aspirin also becoming increasingly unpopular

Growth is challenged as several medications move from OTC to BTH, impacting brand awareness and value sales

CATEGORY DATA

  • Table 12 Sales of Analgesics by Category: Value 2015-2020
  • Table 13 Sales of Analgesics by Category: % Value Growth 2015-2020
  • Table 14 NBO Company Shares of Analgesics: % Value 2016-2020
  • Table 15 LBN Brand Shares of Analgesics: % Value 2017-2020
  • Table 16 Forecast Sales of Analgesics by Category: Value 2020-2025
  • Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Supervision of the distribution of vasoconstrictors and distrust of anti-cough medicines leads to a decline in value growth for 2020

Antihistamines/allergy remedies (systemic) drive growth as the early Spring has consumers reaching for solutions to hay fever and pollen-related allergies

Solinest continues to grow through the positive performance of Ricola, while Reckitt Benckiser is set to lose share

RECOVERY AND OPPORTUNITIES

Growth continues to record a decline over the forecast period, as antihistamines/allergy remedies (systemic) remain the key driver of growth

A move to behind-the-counter impacts growth over the forecast period, while Strepfen lozenges become prescription only

The growing mistrust of cold products increases consumers interest in natural alternatives across the forecast period

CATEGORY DATA

  • Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
  • Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
  • Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
  • Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
  • Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
  • Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Lifestyle changes due to home seclusion lead to an increase in sales of digestive remedies during Q1 and Q2 of 2020

Value growth aligns to 2019; however, motion sickness remedies see a decline in demand during Q1 and Q2, as the COVID-19 lockdown stifles sales

Johnson & Johnson leads the landscape with Imodium, as Sanofi offers the most popular product, Maalox

RECOVERY AND OPPORTUNITIES

Higher growth across the forecast period, as antacids continue to drive sales for digestive remedies

Findings published in 2020 are set to impact growth for certain diarrhoeal remedies over the forecast period

Natural remedies set to challenge growth across the forecasts period, as COVID-19 increases the interest in health and wellbeing

CATEGORY DATA

  • Table 24 Sales of Digestive Remedies by Category: Value 2015-2020
  • Table 25 Sales of Digestive Remedies by Category: % Value Growth 2015-2020
  • Table 26 NBO Company Shares of Digestive Remedies: % Value 2016-2020
  • Table 27 LBN Brand Shares of Digestive Remedies: % Value 2017-2020
  • Table 28 Forecast Sales of Digestive Remedies by Category: Value 2020-2025
  • Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

COVID-19 increases skin conditions caused by stress, however, lockdown and social distancing reduces demand for antiparasitics/lice (head and body) treatments

Negative press surrounding side-effects of Propecia stifle growth; however, hair loss treatments remain on an upward trend

Johnson & Johnson Sante Beaute France retains its lead, while Bayer Sante Familiale offers leading product Bepanthen

RECOVERY AND OPPORTUNITIES

Growth will increase year-on-year across the forecast period, as hair loss treatment and antiparasitics/lice (head and body) treatments recover in 2021

Lice treatment centres are set to stifle growth for antiparasitics/lice (head and body) treatments, across the forecast period

The increasing popularity of natural products, as well as a shift towards dietary changes, may stifle growth across the forecast period

CATEGORY DATA

  • Table 30 Sales of Dermatologicals by Category: Value 2015-2020
  • Table 31 Sales of Dermatologicals by Category: % Value Growth 2015-2020
  • Table 32 NBO Company Shares of Dermatologicals: % Value 2016-2020
  • Table 33 LBN Brand Shares of Dermatologicals: % Value 2017-2020
  • Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2017-2020
  • Table 35 Forecast Sales of Dermatologicals by Category: Value 2020-2025
  • Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Growth is stifled as the government implements limitations on nicotine substitutes, during the initial outbreak of COVID-19

The national tobacco control plan and the National Authority for Health both recommend the use of NRT smoking cessation aids, boosting growth in the landscape

Pierre Fabre Health Care and Johnson & Johnson Laboratories lead the landscape, making it tough for competitors to gain share

RECOVERY AND OPPORTUNITIES

The COVID-19 virus motivates some consumers to purchase nicotine substitutes, however, growth continues to decline across the forecast period

The reimbursement of NRT smoking cessation aids will negatively impact growth for OTC goods across the forecast period

Competition from e-vapour products contributes to the decline in volume and value growth across the forecast period

CATEGORY INDICATORS

  • Table 37 Number of Smokers by Gender 2015-2020

CATEGORY DATA

  • Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2015-2020
  • Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2015-2020
  • Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2016-2020
  • Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2017-2020
  • Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2020-2025
  • Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

An increase in stress and anxiety due to the outbreak of COVID-19 boosts growth for sleep aids in 2020

A quarter of French people suffer from a lack of sleep, a statistic that boosts value growth for sleep aids

Players benefit from the outbreak of COVID-19, with most players recording double-digit growth during 2020

RECOVERY AND OPPORTUNITIES

Positive results predicted across the forecast period, with double-digit value growth until 2025

Growth for sleeping aids is set to benefit from consumers increased concerns around prescription sleeping pills

Growth is challenged by the number of alternative options, impacting sales of sleeping aids

CATEGORY DATA

  • Table 44 Sales of Sleep Aids: Value 2015-2020
  • Table 45 Sales of Sleep Aids: % Value Growth 2015-2020
  • Table 46 NBO Company Shares of Sleep Aids: % Value 2016-2020
  • Table 47 LBN Brand Shares of Sleep Aids: % Value 2017-2020
  • Table 48 Forecast Sales of Sleep Aids: Value 2020-2025
  • Table 49 Forecast Sales of Sleep Aids: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Growth is set to be positive, as the hay fever season begins earlier in 2020, boosting sales for eye care products

COVID-19 drives the use of eyedrops, as the lockdown increases use of screen time for both work and in-home entertainment

Laboratoires Chauvin retains its lead, as all players record positive growth as consumers continue to invest in products during the outbreak of COVID-19

RECOVERY AND OPPORTUNITIES

Ongoing growth will be supported by digital devices and screen use, which may continue to rise following habits established during the outbreak of COVID-19

Half of the local population could suffer from allergies within the next 20 years, with rising levels boosting growth for eye care across the forecast period

Standard eye care benefits from increasing cases of dry eye disease, with the ageing population boosting growth

CATEGORY DATA

  • Table 50 Sales of Eye Care by Category: Value 2015-2020
  • Table 51 Sales of Eye Care by Category: % Value Growth 2015-2020
  • Table 52 NBO Company Shares of Eye Care: % Value 2016-2020
  • Table 53 LBN Brand Shares of Eye Care: % Value 2017-2020
  • Table 54 Forecast Sales of Eye Care by Category: Value 2020-2025
  • Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

COVID-19 leads to a decline in value growth, as lockdown reduces physical activity and injuries

A lack of innovation stifles growth; however, sticking plasters/adhesive bandages lead the landscape, with a wide variety of goods

Laboratoires URGO continues to grow its share in 2020, while Laboratories Mercurochrome benefits from offering a wide range of products

RECOVERY AND OPPORTUNITIES

Growth will be supported by the return to outdoor activities, with consumers taking part in their normal routines following the COVID-19 restrictions

The ageing population supports ongoing growth across the forecast period, with older consumers more likely to need wound care items

Despite positive values sales, demographic trends are set to stifle growth across the forecast period

CATEGORY DATA

  • Table 56 Sales of Wound Care by Category: Value 2015-2020
  • Table 57 Sales of Wound Care by Category: % Value Growth 2015-2020
  • Table 58 NBO Company Shares of Wound Care: % Value 2016-2020
  • Table 59 LBN Brand Shares of Wound Care: % Value 2017-2020
  • Table 60 Forecast Sales of Wound Care by Category: Value 2020-2025
  • Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

COVID-19 leads to a considerable uplift in growth, as consumers stockpile vitamins that benefit the immune system

Multivitamins record double-digit growth, despite being challenged by the national press that recommends relying on food sources instead

The high demand for vitamins boosts sales for major players, as Berocca increases its market share

RECOVERY AND OPPORTUNITIES

Growth will decline following the uplift aligned to the COVID-19 outbreak; however, sales will continue to benefit from consumers maintaining the habit of taking vitamins

Multivitamins will continue out selling single vitamins across the forecast period

Innovations focused on vitamin C, and immunity-boosting ingredients is predicted for the forecast period

CATEGORY DATA

  • Table 62 Sales of Vitamins by Category: Value 2015-2020
  • Table 63 Sales of Vitamins by Category: % Value Growth 2015-2020
  • Table 64 Sales of Multivitamins by Positioning: % Value 2015-2020
  • Table 65 NBO Company Shares of Vitamins: % Value 2016-2020
  • Table 66 LBN Brand Shares of Vitamins: % Value 2017-2020
  • Table 67 Forecast Sales of Vitamins by Category: Value 2020-2025
  • Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

COVID-19 increases sales, as consumers reach for dietary supplements to aid their immune system and boost their energy levels

Probiotics, and those supplements that aid relaxation and calm stress, have seen an increase in growth due to the impact of COVID-19

Merck Medication Familiale SAS boosts sales of Bion due to the outbreak of COVID-19, whereas Arkogelules from Laboratoires Arkopharma SA loses share

RECOVERY AND OPPORTUNITIES

Growth across the forecast period will remain positive, driven by combination herbal/traditional dietary supplements

Probiotic supplements continue to drive positive growth, as gut health becomes increasingly important

A lack of regulations leads to consumers questioning effectiveness, challenging growth across the forecast period

CATEGORY DATA

  • Table 69 Sales of Dietary Supplements by Category: Value 2015-2020
  • Table 70 Sales of Dietary Supplements by Category: % Value Growth 2015-2020
  • Table 71 Sales of Dietary Supplements by Positioning: % Value 2015-2020
  • Table 72 NBO Company Shares of Dietary Supplements: % Value 2016-2020
  • Table 73 LBN Brand Shares of Dietary Supplements: % Value 2017-2020
  • Table 74 Forecast Sales of Dietary Supplements by Category: Value 2020-2025
  • Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Weight gain acquired during the COVID-19 lockdown period, boosts sales of weight loss supplements

A decline in value growth reflects the growing attitude that a healthier diet and exercise are the key to weight management, above quick-fix solutions

Nutrition & Sante maintains its lead, as Feed continues to gain a solid reputation

RECOVERY AND OPPORTUNITIES

Value growth is set to improve across the forecast period, with all areas recording positive growth by 2022

Slimming tea will lead both volume and value growth across the forecast period

Weight loss supplements offered by sports or nutrition players provide an opportunity for growth across the forecast period

CATEGORY DATA

  • Table 76 Sales of Weight Management and Wellbeing by Category: Value 2015-2020
  • Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2015-2020
  • Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2016-2020
  • Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2017-2020
  • Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2020-2025
  • Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Value sales are stifled by the closure of gyms across the country; however, growth remains positive as consumers use sports nutrition to maintain muscle

As non-essential retailers close, an increase in share will be seen from supermarkets and hypermarkets, as well as e-commerce

Myprotein remains the leading brand, increasing its share on the highly competitive landscape

RECOVERY AND OPPORTUNITIES

Growth will recover following the outbreak of COVID-19, as consumers return to their previous fitness regimes

Growth opportunities include the growing vegan and flexitarian lifestyles, as well as high protein diets and rising on-the-go-consumption of protein/energy bars

The growth of e-commerce and an increase in online players is set to drive sales across the forecast period

CATEGORY DATA

  • Table 82 Sales of Sports Nutrition by Category: Value 2015-2020
  • Table 83 Sales of Sports Nutrition by Category: % Value Growth 2015-2020
  • Table 84 NBO Company Shares of Sports Nutrition: % Value 2016-2020
  • Table 85 LBN Brand Shares of Sports Nutrition: % Value 2017-2020
  • Table 86 Forecast Sales of Sports Nutrition by Category: Value 2020-2025
  • Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

The outbreak of COVID-19 boosts the consumption of products that help relieve stress and aid relaxation

Herbal/traditional sleep aids records the strongest value growth, as heightened anxieties increase sleep deprivation

Laboratoires Arkopharma leads the landscape in 2020, benefiting from the popularity of both Arkogelules and Arkofluides

RECOVERY AND OPPORTUNITIES

Growth is set to return to pre-COVID-19 levels from 2021, remaining positive across the forecast period

Herbal/traditional products face growing competition from aromatherapy, set to stifle growth across the forecast period

A shift from OTC to herbal/traditional products, aligned to the growing health trend, aids strong growth across the forecast period

CATEGORY DATA

  • Table 88 Sales of Herbal/Traditional Products by Category: Value 2015-2020
  • Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2015-2020
  • Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2016-2020
  • Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2017-2020
  • Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2020-2025
  • Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2020-2025

KEY DATA FINDINGS

2020 IMPACT

Paediatric vitamins and dietary supplements, nappy (diaper) rash treatments and paediatric acetaminophen all benefit from the outbreak of the COVID-19 virus

Cough/cold remedies are set to record the sharpest decline in growth as mistrust for the products grows

Bayer Sante Familiale SAS leads the landscape, with Merck Medication Familiale SAS also benefiting from the current climate

RECOVERY AND OPPORTUNITIES

Following an uplift in sales due to COVID-19, sales are set to decline from 2021; however, growth will remain steady and positive across the forecast period

The landscape will be increasingly challenged by natural alternatives, as OTC options continue to cause concern

Innovation remains limited; however, opportunities exist for paediatric vitamins and dietary supplements

CATEGORY DATA

  • Table 94 Sales of Paediatric Consumer Health by Category: Value 2015-2020
  • Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2015-2020
  • Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2020
  • Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2016-2020
  • Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2017-2020
  • Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2020-2025
  • Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2020-2025
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.